These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 29654727)

  • 1. Comparative proteomic analysis of human malignant ascitic fluids for the development of gastric cancer biomarkers.
    Jin J; Son M; Kim H; Kim H; Kong SH; Kim HK; Kim Y; Han D
    Clin Biochem; 2018 Jun; 56():55-61. PubMed ID: 29654727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomal miRNAs from Peritoneum Lavage Fluid as Potential Prognostic Biomarkers of Peritoneal Metastasis in Gastric Cancer.
    Tokuhisa M; Ichikawa Y; Kosaka N; Ochiya T; Yashiro M; Hirakawa K; Kosaka T; Makino H; Akiyama H; Kunisaki C; Endo I
    PLoS One; 2015; 10(7):e0130472. PubMed ID: 26208314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
    Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
    Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant gene methylation in the peritoneal fluid is a risk factor predicting peritoneal recurrence in gastric cancer.
    Hiraki M; Kitajima Y; Sato S; Nakamura J; Hashiguchi K; Noshiro H; Miyazaki K
    World J Gastroenterol; 2010 Jan; 16(3):330-8. PubMed ID: 20082478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic alterations and their clinical implications in gastric cancer peritoneal carcinomatosis revealed by whole-exome sequencing of malignant ascites.
    Lim B; Kim C; Kim JH; Kwon WS; Lee WS; Kim JM; Park JY; Kim HS; Park KH; Kim TS; Park JL; Chung HC; Rha SY; Kim SY
    Oncotarget; 2016 Feb; 7(7):8055-66. PubMed ID: 26811494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Candidate Biomarkers in Malignant Ascites from Patients with Hepatocellular Carcinoma by iTRAQ-Based Quantitative Proteomic Analysis.
    Zhang J; Liang R; Wei J; Ye J; He Q; ChunlingYuan ; Ye J; Li Y; Liu Z; Lin Y
    Biomed Res Int; 2018; 2018():5484976. PubMed ID: 30345303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of a variety of biological parameters in distinguishing cirrhotic from malignant ascites.
    Alexandrakis MG; Moschandrea J; Kyriakou DS; Alexandraki R; Kouroumalis E
    Int J Biol Markers; 2001; 16(1):45-9. PubMed ID: 11288954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical evaluation of polyamine assay in diagnosis of malignant ascites].
    Peng A; Zhao S; Zhang X; Zhang G
    Hunan Yi Ke Da Xue Xue Bao; 1997; 22(1):59-62, 65. PubMed ID: 9868032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laminin concentration in ascites of patients with hepatic cirrhosis and peritoneal carcinomatosis.
    Catarino RM; Lopes JD; Forones NM; Parise ER
    Braz J Med Biol Res; 2005 Feb; 38(2):271-6. PubMed ID: 15785839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-free and concentrated ascites reinfusion therapy (CART) for management of massive malignant ascites in gastric cancer patients with peritoneal metastasis treated with intravenous and intraperitoneal paclitaxel with oral S-1.
    Yamaguchi H; Kitayama J; Emoto S; Ishigami H; Ito T; Hanafusa N; Watanabe T
    Eur J Surg Oncol; 2015 Jul; 41(7):875-80. PubMed ID: 25986856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of CT-defined minimal ascites in patients with gastric cancer.
    Chang DK; Kim JW; Kim BK; Lee KL; Song CS; Han JK; Song IS
    World J Gastroenterol; 2005 Nov; 11(42):6587-92. PubMed ID: 16425349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of survivin mRNA in peritoneal lavage fluid from patients with gastric carcinoma.
    Wang ZN; Xu HM; Jiang L; Zhou X; Lu C; Zhang X
    Chin Med J (Engl); 2004 Aug; 117(8):1210-7. PubMed ID: 15361297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of pepsinogen C as a potential biomarker for gastric cancer using a histo-proteomic approach.
    Melle C; Ernst G; Schimmel B; Bleul A; Kaufmann R; Hommann M; Richter KK; Daffner W; Settmacher U; Claussen U; von Eggeling F
    J Proteome Res; 2005; 4(5):1799-804. PubMed ID: 16212435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-reactive protein and insulin-like growth factor-1 in differential diagnosis of ascites.
    Abdel-Razik A; Eldars W; Elhelaly R; Elzehery R
    J Gastroenterol Hepatol; 2016 Nov; 31(11):1868-1873. PubMed ID: 27010362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total discrimination of peritoneal malignant ascites from cirrhosis- and hepatocarcinoma-associated ascites by assays of ascitic cholesterol and lactate dehydrogenase.
    Castaldo G; Oriani G; Cimino L; Topa M; Mostarda I; Castellano L; Del Vecchio-Blanco C; Budillon G; Salvatore F; Sacchetti L
    Clin Chem; 1994 Mar; 40(3):478-83. PubMed ID: 8131285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical significance of vascular endothelial growth factor in malignant ascites.
    Zhan N; Dong WG; Wang J
    Tumour Biol; 2016 Mar; 37(3):3719-25. PubMed ID: 26462841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of ascitic fluid analysis in patients with malignancy-related ascites.
    Salerno F; Restelli B; Incerti P; Annoni G; Capozza L; Badalamenti S; Lampertico P; Mojana E; Moser P; Tommasini M
    Scand J Gastroenterol; 1990 Mar; 25(3):251-6. PubMed ID: 1690913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Genesis of fibronectin in ascites--detection of cellular and plasma fibronectin in portal and malignant ascites].
    Rieder H; Ramadori G; Meyer zum Büschenfelde KH
    Z Gastroenterol; 1991 Jan; 29(1):16-21. PubMed ID: 2058224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant ascites-derived exosomes promote peritoneal tumor cell dissemination and reveal a distinct miRNA signature in advanced gastric cancer.
    Hu Y; Qi C; Liu X; Zhang C; Gao J; Wu Y; Yang J; Zhao Q; Li J; Wang X; Shen L
    Cancer Lett; 2019 Aug; 457():142-150. PubMed ID: 31075288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative proteomic and genomic profiling reveals metastasis-related protein expression patterns in gastric cancer cells.
    Chen YR; Juan HF; Huang HC; Huang HH; Lee YJ; Liao MY; Tseng CW; Lin LL; Chen JY; Wang MJ; Chen JH; Chen YJ
    J Proteome Res; 2006 Oct; 5(10):2727-42. PubMed ID: 17022644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.